Amsterdam–based Philips has received de novo clearance from the FDA for its IntelliSite imaging device.

For the authorization, the FDA required special controls to assure the digital imaging system’s precision, reliability, and clinical relevance.

The IntelliSite device was designed to streamline workflow and increase accuracies. The device enables pathologists to view and diagnose digital images of surgical pathology slides. — Cynthia Jessup